Next 10 |
home / stock / cmopf / cmopf news
2024-07-24 09:27:06 ET More on Cosmo Pharmaceuticals N.V. Historical earnings data for Cosmo Pharmaceuticals N.V. Dividend scorecard for Cosmo Pharmaceuticals N.V. Financial information for Cosmo Pharmaceuticals N.V. Read the full article on Seeking Alpha ...
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - July 24, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its 2024 half year results. Key highlights Health Tech: Upfront payment of $100 million...
Dublin, Ireland--(Newsfile Corp. - July 9, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced today that it will publish its Half-Year 2024 results on Wednesday, 24 July 2024 at 07:00 am CEST. Cosmo invites investors, financial analysts and business/...
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of 90% versus last year Shareholders approved all other proposals of the Board of Directors, including the adoption of the FY2023 annual accounts and updates to the remuneration p...
Dublin, Ireland--(Newsfile Corp. - June 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) reported that its partner and exclusive licensee of Lumeblue ® (Methylene Blue MMX ® ) for China, China Medical System Holdings Limited (“CMS”) (S...
2024-06-05 11:54:24 ET More on Cosmo Pharmaceuticals N.V. Historical earnings data for Cosmo Pharmaceuticals N.V. Dividend scorecard for Cosmo Pharmaceuticals N.V. Financial information for Cosmo Pharmaceuticals N.V. Read the full article on Seeking Alpha ...
2024-06-03 09:28:31 ET More on Cosmo Pharmaceuticals N.V. Historical earnings data for Cosmo Pharmaceuticals N.V. Financial information for Cosmo Pharmaceuticals N.V. Read the full article on Seeking Alpha For further details see: Cosmo Pharmaceuticals to...
Dublin, Ireland--(Newsfile Corp. - June 3, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) with its Cosmo Intelligent Medical Devices division (“Cosmo IMD”) is consolidating its strategy to accelerate the adoption of responsible and regulated AI in ...
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - May 31, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its final audited results for the financial year 2023. Financial highlights As previously announced...
Dublin, Ireland--(Newsfile Corp. - May 24, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced that its shareholders approved all agenda items at today's annual general meeting of shareholders. A total of 7,417,916 ordinary shares in the share cap...
News, Short Squeeze, Breakout and More Instantly...
Chi Mei Optoelectronics Corp Sponsored Reg S GDR Company Name:
CMOPF Stock Symbol:
OTCMKTS Market:
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - July 24, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its 2024 half year results. Key highlights Health Tech: Upfront payment of $100 million...
Dublin, Ireland--(Newsfile Corp. - July 9, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced today that it will publish its Half-Year 2024 results on Wednesday, 24 July 2024 at 07:00 am CEST. Cosmo invites investors, financial analysts and business/...
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of 90% versus last year Shareholders approved all other proposals of the Board of Directors, including the adoption of the FY2023 annual accounts and updates to the remuneration p...